Key players in PCOS Treatment
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Bayer AG |
bayer.com (opens in a new tab) | 1,320 reports |
| 2 |  Merck & Co., Inc. |
merck.com (opens in a new tab) | 1,320 reports |
| 3 | Ferring Pharmaceuticals | — | 165 reports |
| 4 |  Novo Nordisk A/S |
novo.com (opens in a new tab) | 495 reports |
| 5 | Organon | — | 99 reports |
Also active in PCOS Treatment
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| Cosette | |
| Appco | |
| Granata Bio Corp | |
| Rubicon Research | |
| Accord Healthcare | |
| Novitium Pharma | |
| Ascent Pharmaceuticals Inc |
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
PCOS Treatment reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full PCOS Treatment report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.